… in the settlement agreement. AstraZeneca has said that this … side effect of using prescription drugs . However, the company still … 2024. A spokesperson for AstraZeneca said: “ AstraZeneca continues to believe these … parent company of Pharmaceutical Technology.

Biopharmaceutical company AstraZeneca has agreed to pay $425 million to settle product liability suits over two heartburn drugs, Prilosec and Nexium, according to an Oct. 3 news release.

AstraZeneca has agreed to settle substantially all of the product liability litigation for its anti-acid medications, Nexium and Prilosec, paying $425M.

AstraZeneca will pay a $425million (£351million) settlement to bring an end to claims in US courts regarding its heartburn drugs Nexium and Prilosec.

Drugmaker says settlements will avoid costly litigation and adds claims are ‘without merit’

The type of drugs have been linked to kidney failure, liver damage and bone problems

The FTSE 100 listed firm said it denies wrongdoing, adding that the settlements will avoid lengthy and costly litigation.

Among the companies with reports and trading updates today are Boohoo, Greggs, AstraZeneca, Diageo, Petrofac and Edinburgh Investment Trust.

The Kazakh authorities are waiting for Pfizer and AstraZeneca companies to start production of drugs in the country, Report informs, citing the press service of the Cabinet of Ministers.

RSV is the second most prevalent cause of newborn death under one year of age, behind malaria, and presents a huge worldwide public health concern, particularly for children.